Transcept Pharmaceuticals to Present at Cowen and Company Health Care Conference on March 6

    Transcept Pharmaceuticals to Present at Cowen and Company Health Care
                            Conference on March 6

PR Newswire

POINT RICHMOND, Calif., Feb. 28, 2013

POINT RICHMOND, Calif., Feb. 28, 2013 /PRNewswire/ --Transcept
Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company
focused on the development and commercialization of proprietary products that
address important therapeutic needs in the field of neuroscience, announced
today that Transcept management is scheduled to present a general corporate
overview at the 33^rd Annual Cowen and Company Health Care Conference on March
6, 2013, at 8:00 a.m. Eastern Time.

A live audio webcast of the presentation will be available in the investor
relations section of the Transcept website at www.transcept.com, and a replay
will be available there for approximately 30 days following the event.

About Transcept Pharmaceuticals
Transcept Pharmaceuticals, Inc.is a specialty pharmaceutical company focused
on the development and commercialization of proprietary products that address
important therapeutic needs in the field of neuroscience. Intermezzo®
(zolpidem tartrate) sublingual tablet C-IV is the firstFDAapproved Transcept
product.PurduePharma holds commercialization and development rights for
Intermezzo in the United States. For further information about Transcept,
please visit www.transcept.com. For information about Intermezzo, please visit
www.MyIntermezzo.com.

Contact:
Transcept Pharmaceuticals, Inc.
Leone Patterson
Vice President, Chief Financial Officer
(510) 215-3500
lpatterson@transcept.com

SOURCE Transcept Pharmaceuticals, Inc.

Website: http://www.transcept.com
 
Press spacebar to pause and continue. Press esc to stop.